Lead Product(s) : 3-Hydroxybutanoate
Therapeutic Area : Undisclosed
Study Phase : Undisclosed
Sponsor : American Ketone LLC
Deal Size : Inapplicable
Deal Type : Inapplicable
Evaluation of the Safety and Tolerability of Exogenous Ketosis Induced by Free Beta-hydroxybutyrate.
Details : Undisclosed
Product Name : Undisclosed
Product Type : Dietary Supplement
Upfront Cash : Inapplicable
October 18, 2022
Lead Product(s) : 3-Hydroxybutanoate
Therapeutic Area : Undisclosed
Highest Development Status : Undisclosed
Sponsor : American Ketone LLC
Deal Size : Inapplicable
Deal Type : Inapplicable